Insights from the inaugural BMO Obesity Summit with David Lassen

David Lassen, chief clinical officer, recently spoke at the inaugural BMO Obesity Summit about the future of weight-management care as it relates to GLP-1 weight-loss drugs. Here’s a recap of insights he shared on this booming class of drugs and our evidence-based approaches to providing the kind of care we’d want for our loved ones. Read the full story.